Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada
July 12, 2021 09:29 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered into...
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada
June 28, 2021 16:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of Compliance...
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021
June 16, 2021 17:00 ET
|
Medexus Pharmaceuticals Inc
Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021 ...
Medexus Announces Graduation to the Toronto Stock Exchange
June 15, 2021 16:05 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...
Medexus to Present at Raymond James Human Health Innovation Conference
June 14, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will...
Medexus Schedules Fiscal Year 2021 Conference Call
June 11, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...
Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch
June 10, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it has...
Medexus Announces Availability of Triamcinolone Hexacetonide in the United States
June 09, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it is...
Medexus to Present at The LD Micro Virtual Invitational XI on June 8th
June 01, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, June 01, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF), today announced that management will present...
Medexus Announces Amendments to its Credit Agreements
May 27, 2021 17:00 ET
|
Medexus Pharmaceuticals Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO and CHICAGO and MONTREAL, May 27, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc....